In-house services and expertise are uniquely combined with tailored research programmes to streamline therapeutics development Sydney, AUSTRALIA / April 22, 2021 – Grand Pacific CRO, a full-service, global Contract Research Organisation (CRO), is an accessible...
SOmething here something something
Write something this is something do not worry it will be alot of things
What goes into a blog post? Helpful, industry-specific content that: 1) gives readers a useful takeaway, and 2) shows you’re an industry expert. Use your company’s blog posts to opine on current industry topics, humanize your company, and show how your products and...
In-house services and expertise are uniquely combined with tailored research programmes to streamline therapeutics development
Sydney, AUSTRALIA / April 22, 2021 – Grand Pacific CRO, a full-service, global Contract Research Organisation (CRO), is an accessible partner for the development of novel therapies and medical devices. With a keen focus on expediting clinical research, the company is looking to leverage the medical knowledge and industry experience of its leaders while applying patient-centred and proven trials strategies. The overarching aim is to shorten clinical development timelines and associated costs for sponsors.
With headquarters in Sydney, Australia, Grand Pacific CRO has established operations in the Asia-Pacific region, the US and South Africa. As a full service CRO it offers research services across Phase I–IV clinical trials, covering all major therapeutic areas with an emphasis on oncology and infectious diseases. The company additionally provides adjunct services through its Central Laboratory, Site Management Organisation and Central Image Reading Service divisions.
From a background of conducting global clinical trials, the team at Grand Pacific CRO contribute a number of value-added services, from study design, protocol development, patient recruitment, and site management and monitoring to timely data analysis and study report writing. “We are all about delivering flexible, tailored research services,” says CEO, Dr Sasi Suda. “Each trial is unique, requiring different services and supports. At Grand Pacific CRO we can adjust to our clients’ needs, delivering their projects with the utmost commitment.”
By incorporating its own central testing laboratory and image reading services, Grand Pacific CRO is able to fundamentally support all clinical studies in a timely manner. Together with global first-in-class systems, these capabilities allow the company to optimise trials and advance candidate development. “We are minimally reliant on third-party vendors,” notes Dr Suda. “As a consequence, we avoid time-consuming and costly management of outsourced services.”
In-house expertise and a global footprint also allow for a high degree of responsiveness and autonomy. “The ability to provide key services is a game changer that helps manage disruption and keep projects on track,” said Dr Suda. “After the past year, we all understand the business sense and value of that.”